
|Articles|June 9, 2006
Performance-Driven Retained Executive Search
Bench International
Advertisement
HAPPY BIRTHDAY!
We have just celebrated our 31st Anniversary of Building Quality Teams, working globally and exclusively in Health Care
We operate at corporate and senior leadership levels in every area that supports drug development. Current project areas include translational medicine, biomarker strategy, transatlantic regulatory affairs, commercial, full drug development and technology acquisition
Visit our website and see how we can help you and your organization
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
2
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
3
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
4
Pharmaceutical Executive Daily: FDA Approves Datroway
5




